CANCER:

Thymoma

Related cancers:

‹

Thymus Cancer (51)

Thymic Carcinoma (30)

Thymus Cancer (51)

Thymic Carcinoma (30)

›

No biomarker No biomarker	Thymoma Thymoma	GEM-CAP Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	LV5FU2 Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	CaT Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	VIP Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	CAP Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	etoposide IV Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	ifosfamide Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	CAP + prednisone Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	ADOC Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	EP Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	carboplatin Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	pembrolizumab Resistant: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	gemcitabine Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	paclitaxel Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	pemetrexed Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	prednisone + octreotide Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	octreotide Sensitive: A2 - Guideline
No biomarker No biomarker	Thymoma Thymoma	everolimus Sensitive: A2 - Guideline
IGF1R expression IGF1R expression	Thymoma Thymoma	everolimus Resistant: C3 – Early Trials
EIF4EBP1 expression EIF4EBP1 expression	Thymoma Thymoma	everolimus Resistant: C3 – Early Trials
PD-L1 overexpression PD-L1 overexpression	Thymoma Thymoma	pembrolizumab Sensitive: C4 – Case Studies